Skip to main content

Table 3 Feasibility of S-1 administered by 2 schedules

From: Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial

 

Arm A (n = 38)

Arm B (n = 40)

p

Completion rate

73.7% (95% CI: 58.0%–85.0%)

45.0%

(95% CI: 30.7%–60.2%)

0.01

Relative dose intensity

77.2%

(95% CI: 66.8%–87.5%)

58.4%

(95% CI: 47.3%–69.6%)

0.01

  1. Arm A: 4 weeks of oral S-1 and a 2-week rest over 12 months; arm B: 2 weeks of S-1 and a 1-week rest over 12 months; CI confidence interval; p value for the completion rate was calculated by the chi-square test. p value for the relative dose intensity was calculated with the use of the Student t-test